Oral Cancer Therapeutic Market - Global Outlook and Forecast 2021-2027

April 2021 | 93 pages | ID: OF3122864EE3EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Oral Cancer Therapeutic in Global, including the following market information:

Global Oral Cancer Therapeutic Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Oral Cancer Therapeutic market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Cancer Therapeutic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Oral Cancer Therapeutic Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Oral Cancer Therapeutic Market Segment Percentages, By Type, 2020 (%)

• Targeted Therapy
• Chemotherapy

China Oral Cancer Therapeutic Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Oral Cancer Therapeutic Market Segment Percentages, By Application, 2020 (%)

• Floor of Mouth Cancer
• Gum Cancer
• Hard Palate Cancer
• Inner Cheek Cancer (Buccal Mucosa Cancer)
• Lip Cancer
• Others

Global Oral Cancer Therapeutic Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Oral Cancer Therapeutic Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Oral Cancer Therapeutic Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Oral Cancer Therapeutic Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• AstraZeneca Plc
• Bristol-Myers Squibb Co.
• Eli Lilly and Co.
• Endo International Plc
• F. Hoffmann-La Roche Ltd.
• Merck & Co., Inc.
• Mylan NV
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Oral Cancer Therapeutic Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Oral Cancer Therapeutic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ORAL CANCER THERAPEUTIC OVERALL MARKET SIZE

2.1 Global Oral Cancer Therapeutic Market Size: 2021 VS 2027
2.2 Global Oral Cancer Therapeutic Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Oral Cancer Therapeutic Players in Global Market
3.2 Top Global Oral Cancer Therapeutic Companies Ranked by Revenue
3.3 Global Oral Cancer Therapeutic Revenue by Companies
3.4 Top 3 and Top 5 Oral Cancer Therapeutic Companies in Global Market, by Revenue in 2020
3.5 Global Companies Oral Cancer Therapeutic Product Type
3.6 Tier 1, Tier 2 and Tier 3 Oral Cancer Therapeutic Players in Global Market
  3.6.1 List of Global Tier 1 Oral Cancer Therapeutic Companies
  3.6.2 List of Global Tier 2 and Tier 3 Oral Cancer Therapeutic Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Oral Cancer Therapeutic Market Size Markets, 2021 & 2027
  4.1.2 Targeted Therapy
  4.1.3 Chemotherapy
4.2 By Type - Global Oral Cancer Therapeutic Revenue & Forecasts
  4.2.1 By Type - Global Oral Cancer Therapeutic Revenue, 2016-2021
  4.2.2 By Type - Global Oral Cancer Therapeutic Revenue, 2022-2027
  4.2.3 By Type - Global Oral Cancer Therapeutic Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Oral Cancer Therapeutic Market Size, 2021 & 2027
  5.1.2 Floor of Mouth Cancer
  5.1.3 Gum Cancer
  5.1.4 Hard Palate Cancer
  5.1.5 Inner Cheek Cancer (Buccal Mucosa Cancer)
  5.1.6 Lip Cancer
  5.1.7 Others
5.2 By Application - Global Oral Cancer Therapeutic Revenue & Forecasts
  5.2.1 By Application - Global Oral Cancer Therapeutic Revenue, 2016-2021
  5.2.2 By Application - Global Oral Cancer Therapeutic Revenue, 2022-2027
  5.2.3 By Application - Global Oral Cancer Therapeutic Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Oral Cancer Therapeutic Market Size, 2021 & 2027
6.2 By Region - Global Oral Cancer Therapeutic Revenue & Forecasts
  6.2.1 By Region - Global Oral Cancer Therapeutic Revenue, 2016-2021
  6.2.2 By Region - Global Oral Cancer Therapeutic Revenue, 2022-2027
  6.2.3 By Region - Global Oral Cancer Therapeutic Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Oral Cancer Therapeutic Revenue, 2016-2027
  6.3.2 US Oral Cancer Therapeutic Market Size, 2016-2027
  6.3.3 Canada Oral Cancer Therapeutic Market Size, 2016-2027
  6.3.4 Mexico Oral Cancer Therapeutic Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Oral Cancer Therapeutic Revenue, 2016-2027
  6.4.2 Germany Oral Cancer Therapeutic Market Size, 2016-2027
  6.4.3 France Oral Cancer Therapeutic Market Size, 2016-2027
  6.4.4 U.K. Oral Cancer Therapeutic Market Size, 2016-2027
  6.4.5 Italy Oral Cancer Therapeutic Market Size, 2016-2027
  6.4.6 Russia Oral Cancer Therapeutic Market Size, 2016-2027
  6.4.7 Nordic Countries Oral Cancer Therapeutic Market Size, 2016-2027
  6.4.8 Benelux Oral Cancer Therapeutic Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Oral Cancer Therapeutic Revenue, 2016-2027
  6.5.2 China Oral Cancer Therapeutic Market Size, 2016-2027
  6.5.3 Japan Oral Cancer Therapeutic Market Size, 2016-2027
  6.5.4 South Korea Oral Cancer Therapeutic Market Size, 2016-2027
  6.5.5 Southeast Asia Oral Cancer Therapeutic Market Size, 2016-2027
  6.5.6 India Oral Cancer Therapeutic Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Oral Cancer Therapeutic Revenue, 2016-2027
  6.6.2 Brazil Oral Cancer Therapeutic Market Size, 2016-2027
  6.6.3 Argentina Oral Cancer Therapeutic Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Oral Cancer Therapeutic Revenue, 2016-2027
  6.7.2 Turkey Oral Cancer Therapeutic Market Size, 2016-2027
  6.7.3 Israel Oral Cancer Therapeutic Market Size, 2016-2027
  6.7.4 Saudi Arabia Oral Cancer Therapeutic Market Size, 2016-2027
  6.7.5 UAE Oral Cancer Therapeutic Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 AstraZeneca Plc
  7.1.1 AstraZeneca Plc Corporate Summary
  7.1.2 AstraZeneca Plc Business Overview
  7.1.3 AstraZeneca Plc Oral Cancer Therapeutic Major Product Offerings
  7.1.4 AstraZeneca Plc Oral Cancer Therapeutic Revenue in Global (2016-2021)
  7.1.5 AstraZeneca Plc Key News
7.2 Bristol-Myers Squibb Co.
  7.2.1 Bristol-Myers Squibb Co. Corporate Summary
  7.2.2 Bristol-Myers Squibb Co. Business Overview
  7.2.3 Bristol-Myers Squibb Co. Oral Cancer Therapeutic Major Product Offerings
  7.2.4 Bristol-Myers Squibb Co. Oral Cancer Therapeutic Revenue in Global (2016-2021)
  7.2.5 Bristol-Myers Squibb Co. Key News
7.3 Eli Lilly and Co.
  7.3.1 Eli Lilly and Co. Corporate Summary
  7.3.2 Eli Lilly and Co. Business Overview
  7.3.3 Eli Lilly and Co. Oral Cancer Therapeutic Major Product Offerings
  7.3.4 Eli Lilly and Co. Oral Cancer Therapeutic Revenue in Global (2016-2021)
  7.3.5 Eli Lilly and Co. Key News
7.4 Endo International Plc
  7.4.1 Endo International Plc Corporate Summary
  7.4.2 Endo International Plc Business Overview
  7.4.3 Endo International Plc Oral Cancer Therapeutic Major Product Offerings
  7.4.4 Endo International Plc Oral Cancer Therapeutic Revenue in Global (2016-2021)
  7.4.5 Endo International Plc Key News
7.5 F. Hoffmann-La Roche Ltd.
  7.5.1 F. Hoffmann-La Roche Ltd. Corporate Summary
  7.5.2 F. Hoffmann-La Roche Ltd. Business Overview
  7.5.3 F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Major Product Offerings
  7.5.4 F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Revenue in Global (2016-2021)
  7.5.5 F. Hoffmann-La Roche Ltd. Key News
7.6 Merck & Co., Inc.
  7.6.1 Merck & Co., Inc. Corporate Summary
  7.6.2 Merck & Co., Inc. Business Overview
  7.6.3 Merck & Co., Inc. Oral Cancer Therapeutic Major Product Offerings
  7.6.4 Merck & Co., Inc. Oral Cancer Therapeutic Revenue in Global (2016-2021)
  7.6.5 Merck & Co., Inc. Key News
7.7 Mylan NV
  7.7.1 Mylan NV Corporate Summary
  7.7.2 Mylan NV Business Overview
  7.7.3 Mylan NV Oral Cancer Therapeutic Major Product Offerings
  7.4.4 Mylan NV Oral Cancer Therapeutic Revenue in Global (2016-2021)
  7.7.5 Mylan NV Key News
7.8 Pfizer Inc.
  7.8.1 Pfizer Inc. Corporate Summary
  7.8.2 Pfizer Inc. Business Overview
  7.8.3 Pfizer Inc. Oral Cancer Therapeutic Major Product Offerings
  7.8.4 Pfizer Inc. Oral Cancer Therapeutic Revenue in Global (2016-2021)
  7.8.5 Pfizer Inc. Key News
7.9 Sanofi
  7.9.1 Sanofi Corporate Summary
  7.9.2 Sanofi Business Overview
  7.9.3 Sanofi Oral Cancer Therapeutic Major Product Offerings
  7.9.4 Sanofi Oral Cancer Therapeutic Revenue in Global (2016-2021)
  7.9.5 Sanofi Key News
7.10 Teva Pharmaceutical Industries Ltd.
  7.10.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
  7.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
  7.10.3 Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Major Product Offerings
  7.10.4 Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Revenue in Global (2016-2021)
  7.10.5 Teva Pharmaceutical Industries Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Oral Cancer Therapeutic Market Opportunities & Trends in Global Market
Table 2. Oral Cancer Therapeutic Market Drivers in Global Market
Table 3. Oral Cancer Therapeutic Market Restraints in Global Market
Table 4. Key Players of Oral Cancer Therapeutic in Global Market
Table 5. Top Oral Cancer Therapeutic Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Oral Cancer Therapeutic Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Oral Cancer Therapeutic Revenue Share by Companies, 2016-2021
Table 8. Global Companies Oral Cancer Therapeutic Product Type
Table 9. List of Global Tier 1 Oral Cancer Therapeutic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Cancer Therapeutic Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Oral Cancer Therapeutic Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Oral Cancer Therapeutic Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Oral Cancer Therapeutic Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Oral Cancer Therapeutic Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Oral Cancer Therapeutic Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Oral Cancer Therapeutic Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Oral Cancer Therapeutic Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Oral Cancer Therapeutic Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Oral Cancer Therapeutic Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Oral Cancer Therapeutic Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Oral Cancer Therapeutic Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Oral Cancer Therapeutic Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Oral Cancer Therapeutic Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Oral Cancer Therapeutic Revenue, (US$, Mn), 2022-2027
Table 30. AstraZeneca Plc Corporate Summary
Table 31. AstraZeneca Plc Oral Cancer Therapeutic Product Offerings
Table 32. AstraZeneca Plc Oral Cancer Therapeutic Revenue (US$, Mn), (2016-2021)
Table 33. Bristol-Myers Squibb Co. Corporate Summary
Table 34. Bristol-Myers Squibb Co. Oral Cancer Therapeutic Product Offerings
Table 35. Bristol-Myers Squibb Co. Oral Cancer Therapeutic Revenue (US$, Mn), (2016-2021)
Table 36. Eli Lilly and Co. Corporate Summary
Table 37. Eli Lilly and Co. Oral Cancer Therapeutic Product Offerings
Table 38. Eli Lilly and Co. Oral Cancer Therapeutic Revenue (US$, Mn), (2016-2021)
Table 39. Endo International Plc Corporate Summary
Table 40. Endo International Plc Oral Cancer Therapeutic Product Offerings
Table 41. Endo International Plc Oral Cancer Therapeutic Revenue (US$, Mn), (2016-2021)
Table 42. F. Hoffmann-La Roche Ltd. Corporate Summary
Table 43. F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Product Offerings
Table 44. F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Revenue (US$, Mn), (2016-2021)
Table 45. Merck & Co., Inc. Corporate Summary
Table 46. Merck & Co., Inc. Oral Cancer Therapeutic Product Offerings
Table 47. Merck & Co., Inc. Oral Cancer Therapeutic Revenue (US$, Mn), (2016-2021)
Table 48. Mylan NV Corporate Summary
Table 49. Mylan NV Oral Cancer Therapeutic Product Offerings
Table 50. Mylan NV Oral Cancer Therapeutic Revenue (US$, Mn), (2016-2021)
Table 51. Pfizer Inc. Corporate Summary
Table 52. Pfizer Inc. Oral Cancer Therapeutic Product Offerings
Table 53. Pfizer Inc. Oral Cancer Therapeutic Revenue (US$, Mn), (2016-2021)
Table 54. Sanofi Corporate Summary
Table 55. Sanofi Oral Cancer Therapeutic Product Offerings
Table 56. Sanofi Oral Cancer Therapeutic Revenue (US$, Mn), (2016-2021)
Table 57. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 58. Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Product Offerings
Table 59. Teva Pharmaceutical Industries Ltd. Oral Cancer Therapeutic Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Oral Cancer Therapeutic Segment by Type
Figure 2. Oral Cancer Therapeutic Segment by Application
Figure 3. Global Oral Cancer Therapeutic Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Oral Cancer Therapeutic Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Oral Cancer Therapeutic Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Oral Cancer Therapeutic Revenue in 2020
Figure 8. By Type - Global Oral Cancer Therapeutic Revenue Market Share, 2016-2027
Figure 9. By Application - Global Oral Cancer Therapeutic Revenue Market Share, 2016-2027
Figure 10. By Region - Global Oral Cancer Therapeutic Revenue Market Share, 2016-2027
Figure 11. By Country - North America Oral Cancer Therapeutic Revenue Market Share, 2016-2027
Figure 12. US Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Oral Cancer Therapeutic Revenue Market Share, 2016-2027
Figure 16. Germany Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 17. France Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Oral Cancer Therapeutic Revenue Market Share, 2016-2027
Figure 24. China Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 28. India Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Oral Cancer Therapeutic Revenue Market Share, 2016-2027
Figure 30. Brazil Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Oral Cancer Therapeutic Revenue Market Share, 2016-2027
Figure 33. Turkey Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Oral Cancer Therapeutic Revenue, (US$, Mn), 2016-2027
Figure 37. AstraZeneca Plc Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Bristol-Myers Squibb Co. Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Eli Lilly and Co. Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Endo International Plc Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. F. Hoffmann-La Roche Ltd. Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Merck & Co., Inc. Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Mylan NV Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Pfizer Inc. Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Sanofi Oral Cancer Therapeutic Revenue Year Over Year Growth (US$, Mn) & (2016-2021)